• トップページ
  • 診療のご案内
  • センターのご紹介
  • 当施設について
  • 診療関連部門診療科のご案内
  • 採用案内

埼玉県立がんセンター > 論文リスト > 2015年度の論文リスト

ここから本文です。

 

掲載日:2019年6月14日

2015年度の論文リスト

 各年度の論文リスト

 ※ボタンをクリックすると年度ごとに一覧を参照できます

2015年度の論文リスト

Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation.
Shimozato O, Waraya M, Nakashima K, Souda H, Takiguchi N, Yamamoto
H, Takenobu H, Uehara H, Ikeda E, Matsushita S, Kubo N, Nakagawara A,Ozaki T, Kamijo T.
Oncogene. 2015 34:1949-1960. doi: 10.1038/onc.2014.141.

Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivo.
Sai S, Wakai T, Vares G, Yamada S, Kamijo T, Kamada T, Shirai T.
Oncotarget. 2015 Mar 20;6(8):5517-5535. DOI: 10.18632/oncotarget.3584

Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastoma.
Nakazawa A, Haga C, Ohira M, Okita H, Kamijo T, Nakagawara A.
Cancer Sci. 2015 106:766-71. doi: 10.1111/cas.12665.

Characteristics of scratching behavior in ADJM mice (atopic dermatitis from Japanese mice).
Nakasone T, Sato T, Matsushima Y, Inoue T, Kamei C.
Immunopharmacol Immunotoxicol. 2015 37: 202-6. doi: 10.3109/08923973.2014.1001903.

Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells.
Islam SM, Suenaga Y, Takatori A, Ueda Y, Kaneko Y, Kawana H, Itami M, Ohira M, Yokoi S, Nakagawara A.
Cancer Sci. 2015 106:1351-61. doi: 10.1111/cas.12746.

Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas.
Kaneko Y, Suenaga Y, Islam SM, Matsumoto D, Nakamura Y, Ohira M, Yokoi S, Nakagawara A.
Cancer Sci. 2015 106:840-7. doi: 10.1111/cas.12677.

Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation.
Mishra R, Watanabe T, Kimura MT, Koshikawa N, Ikeda M, Uekusa S, Kawashima H, Wang X, Igarashi J, Choudhury D, Grandori C, Kemp CJ, Ohira M, Verma NK, Kobayashi Y, Takeuchi J, Koshinaga T, Nemoto N, Fukuda N, Soma M, Kusafuka T, Fujiwara K, Nagase H.
Cancer Sci 2015 106:421-9. doi: 10.1111/cas.12610.

Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers.
Oberthuer A, Juraeva D, Hero B, Volland R, Sterz C, Schmidt R, Faldum A, Kahlert Y, Engesser A, Asgharzadeh S, Seeger R, Ohira M, Nakagawara A, Scaruffi P, Tonini GP, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Vandesompele J, Speleman F, Noguera R, Piqueras M, Bénard J, Valent A, Avigad S, Yaniv I, Grundy RG, Ortmann M, Shao C, Schwab M, Eils R, Simon T, Theissen J, Berthold F, Westermann F, Brors B, Fischer M.
Clin Cancer Res. 2015 21:1904-15. doi: 10.1158/1078-0432.CCR-14-0817.

Management of pediatric renal tumor: Past and future trials of the Japan Wilms Tumor Study Group.
Oue T, Fukuzawa M, Koshinaga T, Okita H, Nozaki M, Chin M, Kaneko Y, Tanaka Y, Haruta M, Tsuchiya K, Kuwashima S, Takimoto T.
Pediatr Int. 2015 57:828-831. doi: 10.1111/ped.12787.

A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation.
Kaneko Y, Okita H, Haruta M, Arai Y, Oue T, Tanaka Y, Horie H, Hinotsu S, Koshinaga T, Yoneda A, Ohtsuka Y, Taguchi T, Fukuzawa M.
Br J Cancer. 2015 112; 1121-1133. doi: 10.1038/bjc.2015.13.

Active estrogen synthesis and its function in prostate cancer-derived stromal cells. Machioka K, Mizokami A, Yamaguchi Y, Izumi K, Hayashi S, Namiki M.
Anticancer Res. 2015, 35: 221-227.

Differences in stemness properties associated with the heterogeneity of luminal-type breast cancer.
Ito T, Sato N, Yamaguchi Y, Tazawa C, Moriya T, Hirakawa H, Hayashi S.
Clin Breast Cancer. 2015, 15: e93-103. doi: 10.1016/j.clbc.2014.11.002.

NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.
Namiki T, Yaguchi T, Nakamura K, Valencia JC, Coelho SG, Yin L, Kawaguchi M, Vieira WD, Kaneko Y, Tanemura A, Katayama I, Yokozeki H, Kawakami Y, Hearing VJ.
Cancer Res. 2015 75: 2708-2715.

Protracted dormancy of pre-leukemic stem cells.
Ford AM, Mansur MB, Furness CL, van Delft FW, Okamura J, Suzuki T, Kobayashi H, Kaneko Y, Greaves M.
Leukemia. 2015 29: 2202-2207.

Cotylenin A and arsenic trioxide cooperatively suppress cell proliferation and cell invasion activity in human breast cancer cells.
Kasukabe T, Okabe-Kado J, Kato N, Honma Y, Kumakura S.
Int J Oncol. 2015 46:841-848. doi: 10.3892/ijo.2014.2760.

Highlights of the twelfth Japan-Korea Joint Symposium on Cancer and Ageing Research.
Suganuma M, Park TJ, Sueoka E, Iida K, Tanaka Y.
J. Cancer Res. Clin. Oncol, 2015 141: 1953-1961. doi: 10.1007/s00432-015-1959-5.

Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA.
Hayashi K, Momoi Y, Tanuma N, Kishimoto A, Ogoh H, Kato H, Suzuki M, Sakamoto Y, Inoue Y, Nomura M, Kiyonari H, Sakayori M, Fukamachi K, Kakugawa Y, Yamashita Y, Ito S, Sato I, Suzuki A, Nishio M, Suganuma M, Watanabe T, Shima H.
Oncogene 2015 34, 4647-4655. doi: 10.1038/onc.2014.398.

Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.
Fujiki H, Sueoka E, Watanabe T, Suganuma M.
J. Cancer Res. Clin Oncol. 2015 141: 1511-1522. doi: 10.1007/s00432-014-1899-5.

家族性腫瘍学 —家族性腫瘍の最新研究動向— II 各論2.原因遺伝子(8) ALK, PHOX2B, KIF1B
大平美紀
日本臨床73巻 増刊号6(通巻第1083号)pp.299-304, 2015. 日本臨床社

Wilms腫瘍(腎芽腫)の分子生物学: 小児固形腫瘍の分子生物学(その4)次世代シークエンサーの時代
金子安比古
小児外科2015 47: 165-170.

家族性腫瘍学:家族性腫瘍の最新研究動向2. 原因遺伝子(26) WT1
金子安比古
日本臨床:2015年8月増刊号: 394-400.

家族性腫瘍学:家族性腫瘍の最新研究動向3. 臓器・領域別家族性腫瘍の臨床 (22) 小児科腫瘍
金子安比古
日本臨床:2015年8月増刊号: 534-538.

お問い合わせ

病院局 がんセンター  

郵便番号362-0806 埼玉県北足立郡伊奈町小室780番地 埼玉県立がんセンター

ファックス:048-722-1129

より良いウェブサイトにするためにみなさまのご意見をお聞かせください

このページの情報は役に立ちましたか?

このページの情報は見つけやすかったですか?